Cargando…

Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions

BACKGROUND: Antimuscarinic agents are the most popular treatment for overactive bladder and their efficacy in man is well documented, producing decreased urinary frequency and an increase in bladder capacity. During cystometry in rats, however, the main effect reported after acute treatment with ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelico, Patrizia, Velasco, Cristina, Guarneri, Luciano, Sironi, Giorgio, Leonardi, Amedeo, Testa, Rodolfo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274333/ https://www.ncbi.nlm.nih.gov/pubmed/16216132 http://dx.doi.org/10.1186/1471-2210-5-14

Ejemplares similares

Oxybutynin and Tolterodine in a Trial for Treatment of Overactive Bladder in Iranian Women
por: Aziminekoo, Elham, et al.
Publicado: (2014)

Comparison of combined treatment with desmopressin plus oxybutynin and desmopressin plus tolterodine in treatment of children with primary nocturnal enuresis
por: Azarfar, Anoush, et al.
Publicado: (2015)

Effects of Level of Consciousness on Urodynamic Procedure in Female Cats
por: Li, Wen Ji, et al.
Publicado: (2011)

Efficacy of tolterodine in children with overactive bladder
por: Koç, Başak, et al.
Publicado: (2020)

Oxybutynin: an overview of the available formulations
por: McCrery, Rebecca J, et al.
Publicado: (2006)

Oxybutynin as an alternative treatment for hyperhidrosis
por: Delort, Sergio, et al.
Publicado: (2017)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Methadone-Induced Hyperhidrosis Treated With Oxybutynin
por: Hong, Joe, et al.
Publicado: (2017)

Anesthetic agents affect urodynamic parameters and anesthetic depth at doses necessary to facilitate preclinical testing in felines
por: Xu, Jiajie Jessica, et al.
Publicado: (2020)

Tolterodine extended release is well tolerated in older subjects
por: Griebling, T L, et al.
Publicado: (2009)

Update on tolterodine extended-release for treatment of overactive bladder
por: Omotosho, Tola, et al.
Publicado: (2010)

On the Absolute Stereochemistry of Tolterodine: A Circular Dichroism Study
por: Górecki, Marcin, et al.
Publicado: (2019)

Urodynamic function during sleep-like brain states in urethane anesthetized rats
por: Crook, J., et al.
Publicado: (2016)

TRPV4 as a target for bladder overactivity
por: Angelico, Patrizia, et al.
Publicado: (2010)

Oxybutynin topical gel in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2010)

Atypical aquagenic keratoderma treated with oxybutynin chloride
por: Dixit, Niharika, et al.
Publicado: (2018)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
por: Rajabalaya, Rajan, et al.
Publicado: (2016)

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

Factorial design-assisted spectroscopic determination of oxybutynin hydrochloride
por: Yosrey, Eman, et al.
Publicado: (2021)

Oxybutynin-Induced Hyperthermia in a Patient With Parkinson’s Disease
por: Ahmad, Saad, et al.
Publicado: (2021)

The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly
por: Ulahannan, Danny, et al.
Publicado: (2009)

The combination of herbal medicine Weng-li-tong with Tolterodine may be better than Tolterodine alone in the treatment of overactive bladder in women: a randomized placebo-controlled prospective trial
por: Xiao, Dong-dong, et al.
Publicado: (2016)

Anesthetic protocols for urodynamic studies of the lower urinary tract in small rodents—A systematic review
por: Abdelkhalek, Abdelkhalek Samy, et al.
Publicado: (2021)

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
por: Gamble, Tondalaya, et al.
Publicado: (2008)

A Novel Metered Dose Transdermal Spray Formulation for Oxybutynin
por: Bakshi, A., et al.
Publicado: (2008)

Long-term results of oxybutynin use in treating facial hyperhidrosis
por: Wolosker, Nelson, et al.
Publicado: (2014)

A case of probable oxybutynin-induced increase in liver enzymes
por: Alrawashdeh, Haneen, et al.
Publicado: (2018)

Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens
por: Katsuki, Masahito
Publicado: (2023)

Anesthetics and plants: no pain, no brain, and therefore no consciousness
por: Draguhn, Andreas, et al.
Publicado: (2020)

Urodynamics; hydrodynamics of the ureter and renal pelvis
Publicado: (1971)

Tolterodine extended release in the treatment of male oab/storage luts: a systematic review
por: Gacci, Mauro, et al.
Publicado: (2014)

The effect of extended release tolterodine used for overactive bladder treatment on female sexual function
por: Zachariou, Athanasios, et al.
Publicado: (2017)

Formulation and evaluation of taste-masked oral disintegrating tablet containing tolterodine-loaded montmorillonite
por: Taymouri, Somayeh, et al.
Publicado: (2023)

Oxybutynin extended release for the management of overactive bladder: a clinical review
por: Arisco, AM, et al.
Publicado: (2009)

Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years
por: Wolosker, Nelson, et al.
Publicado: (2014)

Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2020)

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018)

Noninvasive Urodynamic Evaluation
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Predicting the future of urodynamics
por: Smith, Ariana L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p23a7aae6e7khba5q3qo8n4u27